BioDiscovery 4 FCPR 4

4 · Axonics Modulation Technologies, Inc. · Filed Nov 26, 2019

Insider Transaction Report

Form 4
Period: 2019-11-22
Transactions
  • Sale

    Common Stock

    2019-11-22$20.73/sh300,000$6,220,5003,257,461 total(indirect: See footnote)
Footnotes (2)
  • [F1]The shares were sold in a public offering pursuant to the Registration Statement of Axonics Modulation Technologies, Inc. on Form S-3 (File No. 333-234546)
  • [F2]2,524,128 shares are held of record by BioDiscovery 4 FCPR ("BioDiscovery") and 733,333 shares are held of record by BioDiscovery 5 ("BioDiscovery 5"). Andera Partners ("Andera") is the manager of BioDiscovery and BioDiscovery 5 and may be deemed to have sole voting and dispositive power over the shares held by BioDiscovery and BioDiscovery 5.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT